Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity
- 14 August 2001
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 309 (3) , 197-201
- https://doi.org/10.1016/s0304-3940(01)02065-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Endocannabinoids control spasticity in a multiple sclerosis modelThe FASEB Journal, 2000
- Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's diseaseThe FASEB Journal, 2000
- The endocannabinoid system as a target for therapeutic drugsTrends in Pharmacological Sciences, 2000
- Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's diseaseMovement Disorders, 1998
- The Perceived Effects of Smoked Cannabis on Patients with Multiple SclerosisEuropean Neurology, 1997
- Molecular Neurobiology of The Cannabinoid ReceptorPublished by Elsevier ,1996
- Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonistEuropean Journal of Pharmacology, 1995
- Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidusAnnals of Neurology, 1994
- Loss of cannabinoid receptors in the substantia nigra in huntington's diseaseNeuroscience, 1993
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988